$LUNG News

Last published 2w ago

2w agoLUNGPulmonx to Participate in Upcoming Investor ConferencesGlobeNewswireREDWOOD CITY, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced that management
2w agoLUNGPulmonx Q3 2026 Earnings Conference Call - PULMONX CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Pulmonics Q3 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. To ask a question during our Q&A session, you will need to pres
2w agoLUNGPulmonx Q3 2026 Earnings Conference Call - PULMONX CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Pulmonics Q3 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. To ask a question during our Q&A session, you will need to pres
2w agoLUNGPulmonx Corp - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
2w agoLUNGPulmonx Reports Third Quarter 2026 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
4w agoLUNGPulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026GlobeNewswireREDWOOD CITY, Calif., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release
2mo agoLUNGPulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireREDWOOD CITY, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) (the "Company" or "Pulmonx"), a global leader in minimally invasive treatments for lung disease, today
2mo agoLUNGPulmonx to Participate in Upcoming Investor ConferencesGlobeNewswireREDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced that management
3mo agoLUNGCG 46TH ANNUAL GROWTH CONFERENCE - PULMONX CORPEarnings Call TranscriptsThank you, everyone, for joining. My name is John Young. I'm one of Canaccord's senior medtech analysts, and we're thrilled to host Pulmonix for this fireside chat. With us today is President and CEO Glenn French and Chi
3mo agoLUNGCG 46TH ANNUAL GROWTH CONFERENCE - PULMONX CORPEarnings Call TranscriptsThank you, everyone, for joining. My name is John Young. I'm one of Canaccord's senior medtech analysts, and we're thrilled to host Pulmonix for this fireside chat. With us today is President and CEO Glenn French and Chi
3mo agoLUNGPulmonx Reports Second Quarter 2026 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
3mo agoLUNGPulmonx to Present at the Canaccord Genuity 46th Annual Growth ConferenceGlobeNewswireREDWOOD CITY, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will
3mo agoLUNGPulmonx to Report Second Quarter 2026 Financial Results on July 29, 2026GlobeNewswireREDWOOD CITY, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release
5mo agoLUNGPulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireREDWOOD CITY, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) (the "Company" or "Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that on June 1,
6mo agoLUNG2026 Global Healthcare Conference - PULMONX CORPEarnings Call TranscriptsGood morning. I'm Rae. I am part of the MedTech device team here at Bank of America and it's my pleasure to welcome Glenn French, President and CEO of Pulmonix here today to present. Welcome Glenn and thanks for being he
6mo agoLUNGPulmonx Q1 2026 Earnings Conference Call - PULMONX CORPEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the Pulmonix First Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the presentation, there will be a question and
6mo agoLUNGPulmonx Reports First Quarter 2026 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
6mo agoLUNGPulmonx to Present at the Bank of America Securities 2026 Health Care ConferenceGlobeNewswireREDWOOD CITY, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
7mo agoLUNGPulmonx to Report First Quarter 2026 Financial Results on April 29, 2026GlobeNewswireREDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
8mo agoLUNGPulmonx Q4 2025 Earnings Conference Call - PULMONX CORPEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Pomonix fourth quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, we'll open up for que
8mo agoLUNGPulmonx Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
8mo agoLUNGPulmonx Announces Closing of up to $60 Million Credit FacilityGlobeNewswireREDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) (the "Company" or "Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced the closing of
8mo agoLUNGPulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026GlobeNewswireREDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
11mo agoLUNGPulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireREDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) (the "Company" or "Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that on
12mo agoLUNGPulmonx Reports Third Quarter 2025 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
12mo agoLUNGPulmonx Q3 2025 Earnings Conference Call - PULMONX CORPEarnings Call TranscriptsHello, and thank you for standing by. Welcome to Pull My Neck's third quarter 2025 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a que
1y agoLUNGPulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025GlobeNewswireGlen French, member of the Board of Directors and former Pulmonx President and Chief Executive Officer, reappointed President and Chief Executive OfficerDerrick Sung, former Pulmonx Chief Financial Officer, appointed
1y agoLUNGPulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025GlobeNewswireREDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it
1y agoLUNGPulmonx to Participate in September Investor ConferencesGlobeNewswireREDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that
1y agoLUNGPulmonx Corporation (LUNG) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoLUNGPulmonx Reports Second Quarter 2025 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
1y agoLUNGPulmonx to Present at the Canaccord Genuity 45th Annual Growth ConferenceGlobeNewswireREDWOOD CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the
1y agoLUNGPulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025GlobeNewswireREDWOOD CITY, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that it
1y agoLUNGPulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewswireREDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the
1y agoLUNGPulmonx to Present at the Bank of America Securities 2025 Health Care ConferenceGlobeNewswireREDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
1y agoLUNGPulmonx Reports First Quarter 2025 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
1y agoLUNGPulmonx to Report First Quarter 2025 Financial Results on April 30, 2025GlobeNewswireREDWOOD CITY, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
1y agoEDAP LUNGEDAP Appoints Glen French to Board of DirectorsGlobeNewswirePDF Version LYON, France, March 3, 2025 -- EDAP TMS SA (NASDAQ:EDAP) ("the Company" or "EDAP"), the global leader in robotic energy-based therapies, today announced the appointment of Glen French to its Board of
1y agoLUNGPulmonx Reports Record Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
1y agoLUNGPulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access DayGlobeNewswireREDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
1y agoLUNGPulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025GlobeNewswireREDWOOD CITY, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
1y agoLUNGPulmonx to Present at the Piper Sandler 36th Annual Healthcare ConferenceGlobeNewswireREDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
1y agoLUNGPulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and ProvidersBusiness WireTwo New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for severe lung disease,
2y agoLUNGPulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswireREDWOOD CITY, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
2y agoLUNGPulmonx to Present at the Stifel 2024 Healthcare ConferenceGlobeNewswireREDWOOD CITY, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be
2y agoLUNGPulmonx Corporation (LUNG) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoLUNGPulmonx Reports Third Quarter 2024 Financial ResultsGlobeNewswireREDWOOD CITY, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported
2y agoLUNGPulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024GlobeNewswireREDWOOD CITY, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx"), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial
2y agoLUNGPulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024GlobeNewswireCONVERT trial data demonstrate AeriSeal® System is safe and effective with 77.6% of patients converted from CV+ to CV- 5-year durability data from LIBERATE study demonstrate positive, durable benefits to patients
2y agoLUNGPulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth ConferenceGlobeNewswireREDWOOD CITY, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be